奇士達(06918.HK)中期總收益減少約10.5%至1.03億元
格隆匯8月31日丨奇士達(06918.HK)發佈公吿,2022年上半年,公司總收益減少約10.5%至約人民幣1.03億元。期間集團的香港及中國分公司的營運均受到疫情嚴重影響,導致直接銷售至歐美的海外客户應占收益的金額暫時減少。
期間錄得淨虧損約人民幣4350萬元,較上年同期純利約人民幣730萬元減少約人民幣5080萬元或695.9%。集團之純利有所減少乃主要由於與2022年6月21日授予僱員購股權的以股份為基礎支付相關的一次性開支的行政費用大幅增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.